Potential predictive factors of osteoporosis in HIV-positive subjects

Alfonso Fausto1, Marco Bongiovanni, Paola Cicconi

  • 1Department of Radiology, Policlinico San Donato, University of Milan, Via Morandi, 30, 20097 San Donato Milanese, Milan, Italy. afausto@sirm.org

Bone
|December 27, 2005
PubMed

Insights

Nearly half of HIV-infected patients exhibit osteopenia or osteoporosis. Higher HIV-RNA levels, female gender, older age, and lower BMI predict bone disease, suggesting HIV itself may play a direct role.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Bone Metabolism

Background:

  • Osteopenia and osteoporosis are frequently reported in HIV-infected individuals.
  • The underlying mechanisms, whether viral or drug-related, remain unclear.
  • Understanding these mechanisms is crucial for managing bone health in this population.

Purpose of the Study:

  • To investigate the prevalence of osteopenia/osteoporosis in HIV-infected adults aged 30-50.
  • To identify predictors of bone disease in this cohort, including traditional risk factors and HIV-specific parameters.
  • To explore the potential direct role of HIV infection in the development of bone disease.

Main Methods:

  • A cohort of 161 HIV-infected outpatients (naive and HAART-treated) underwent interviews, blood/urine tests, and bone mineral density (BMD) measurements via DEXA.
  • Data collected included medical history, lifestyle factors, bone metabolism markers, and HIV-RNA levels.
  • Statistical analyses included logistic and linear regression to identify predictors and differences in BMD.

Main Results:

  • Nearly half (49.7%) of the subjects presented with osteopenia/osteoporosis, with similar rates in naive (45.8%) and HAART-treated (51.3%) groups.
  • Independent predictors of osteopenia/osteoporosis were female gender, older age, low body mass index, and higher HIV-RNA levels.
  • Highly Active Antiretroviral Therapy (HAART) use and altered bone metabolism markers were not significantly associated with osteopenia/osteoporosis.

Conclusions:

  • HIV-infected individuals exhibit a high frequency of osteopenia/osteoporosis.
  • Traditional risk factors are predictive, but higher HIV-RNA levels suggest a potential direct role of HIV in bone disease.
  • Further research is warranted to elucidate the direct impact of HIV on bone metabolism.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...